CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: deferasirox
Accession: CHEBI:49005
browse the term
Definition: A member of the class of triazoles, deferasirox is 1,2,4-triazole substituted by a 4-carboxyphenyl group at position 1 and by 2-hydroxyphenyl groups at positions 3 and 5. An orally active iron chelator, it is used to manage chronic iron overload in patients receiving long-term blood transfusions.
Synonyms: exact_synonym: 4-[3,5-bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]benzoic acid
related_synonym: Exjade; Formula=C21H15N3O4; ICL 670; ICL 670A; InChI=1S/C21H15N3O4/c25-17-7-3-1-5-15(17)19-22-20(16-6-2-4-8-18(16)26)24(23-19)14-11-9-13(10-12-14)21(27)28/h1-12,25-26H,(H,27,28); InChIKey=BOFQWVMAQOTZIW-UHFFFAOYSA-N; SMILES=OC(=O)c1ccc(cc1)-n1nc(nc1-c1ccccc1O)-c1ccccc1O; deferasiroxum
xref: Beilstein:8442898; CAS:201530-41-8; DrugBank:DB01609; Drug_Central:3128; KEGG:D03669
xref_mesh: MESH:C415250
xref: Reaxys:8442898
G
Casp3
caspase 3
increases expression increases activity
ISO
deferasirox results in increased expression of CASP3 protein deferasirox results in increased activity of CASP3 protein
CTD
PMID:21439361
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Ccnt1
cyclin T1
multiple interactions
ISO
deferasirox inhibits the reaction [CDK9 protein binds to CCNT1 protein]
CTD
PMID:17631934
NCBI chr 7:129,687,146...129,718,080
Ensembl chr 7:129,691,209...129,717,871
G
Cdk2
cyclin dependent kinase 2
decreases activity
ISO
deferasirox results in decreased activity of CDK2 protein
CTD
PMID:17631934
NCBI chr 7:1,129,878...1,137,431
Ensembl chr 7:1,129,811...1,137,403
G
Cdk9
cyclin-dependent kinase 9
multiple interactions
ISO
deferasirox inhibits the reaction [CDK9 protein binds to CCNT1 protein]
CTD
PMID:17631934
NCBI chr 3:15,996,467...16,001,315
Ensembl chr 3:15,996,468...16,002,410
G
Clu
clusterin
increases expression
EXP
deferasirox results in increased expression of CLU protein
CTD
PMID:21439361
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
G
Havcr1
hepatitis A virus cellular receptor 1
increases expression
ISO EXP
deferasirox results in increased expression of HAVCR1 protein
CTD
PMID:21439361
NCBI chr10:31,118,667...31,151,730
Ensembl chr10:31,119,088...31,151,698
G
Lcn2
lipocalin 2
increases expression
ISO EXP
deferasirox results in increased expression of LCN2 protein
CTD
PMID:21439361
NCBI chr 3:15,680,688...15,684,033
Ensembl chr 3:15,680,687...15,684,095
G
Polr2a
RNA polymerase II subunit A
decreases phosphorylation
ISO
deferasirox results in decreased phosphorylation of POLR2A protein
CTD
PMID:17631934
NCBI chr10:54,452,438...54,478,486
Ensembl chr10:54,452,441...54,478,455
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all